Stay updated with breaking news from Third Generation Sequencing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology, Application, and End User" report has been...
Dublin, Feb. 09, 2022 (GLOBE NEWSWIRE) -- The "Global Genomics Market: Size, Trends & Forecast with Impact Analysis of COVID-19 (2022-2026)" report...
Search jobs 18-Feb-2021 Sequencing Reagents Market Share & Size, Future Growth, Trends Evaluation, Industry Demands, Regional Analysis and Forecast to 2027 DBMR recently published a detailed study of over 350+ pages in its repository on Sequencing Reagents Market covering interesting aspects of market with supporting development scenario till 2027. The study provides market size break-up by revenue and volume for emerging countries and important business segments along with commentary on trending factors, growth drivers. To perform competitive ana...
G42 Healthcare opens Omics centre in Abu Dhabi ABU DHABI, January 25, 2021 G42 Healthcare, a subsidiary of Abu Dhabi-based technology company Group 42 (G42), has opened its Omics Centre of Excellence in the UAE capital, set to become home to a series of Omics projects such as the Emirati Genome Program. The inauguration ceremony of the latest addition to G42 Healthcare’s initiatives was attended by Abdullah bin Mohammed Al Hamed, Chairman of Department of Health – Abu Dhabi (DoH), and Dr Jamal Mohammed Al Kaabi, Undersecretary of Department of Health – Abu Dhabi. Located in Masdar, A...
G42 Healthcare, a subsidiary of Abu Dhabi-based technology company